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Objectives: To document changes in toe-brachial pressure indices (TBPI) during the 6 months following percutaneous 
transluminal ngioplasty (PTA) and relate these changes to restenosis. Furthermore, to ascertain the effect of administering 
a vasodilator, glyceryI trinitrate (GTN), immediately following PTA. 
Design: Eighty-three technically successful PTA procedures were studied. Fifty-six were for intermittent claudication, 
14for ischaemic rest pain, and 13for non-healing ulcers. Immediately following balloon dilatation an intra-arterial bolus 
of either 150 #g GTN, with or without a 10 mg GTN patch for 24 h, or a saline placebo was administered. TBPI were 
measured before and for 6 h after PTA and then at 24 h, 1 week, 1 month and 6 months. At this time, patency at the 
PTA site was determined by arteriography. 
Results: There was continuing TBPI improvement over 1 month in patients given saline following PTA. In patients 
given GTN, peak TBPI was achieved by 1 week, and corresponded with the TBPI observed immediately following GTN 
administration. Restenosis occurred in 27 (33%) patients, and was significantly more frequent following the procedures 
for rest pain or ulceration, or where a TBPI increase of more than 0.15 by 1 week was observed. 
Conclusions: Haemodynamic changes following PTA continue for at least 1 month, can be modified by GTN administration, 
and are predictive of subsequent restenosis. Measuring the TBPI increase during the first week following PTA 
underestimates total improvement, and may give false reassurance with respect o recurrent disease. 
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Introduction 
Percutaneous transluminal ngioplasty (PTA) was de- 
scribed over 30 years ago, and is now an accepted form 
of revascularisation for leg ischaemia. It is therefore 
surprising that there is little information on early 
changes in large vessel perfusion distal to the PTA 
site, especially in relation to more sustained changes 
or subsequent restenosis. Furthermore, although vaso~ 
dilators are frequently given to treat distal arterial 
spasm following PTA, there is little haemodynamic or 
clinical data to support heir use. 
The aim of this study was to measure non-invasively 
the changes in large vessel perfusion pressure im- 
mediately following PTA for leg ischaemia, both in 
patients given vasodilators during the procedure and 
in those given a placebo. These pressure changes were 
then related to those observed over the next 6 months, 
as well as to the patency of the PTA site at the end of 
that period. 
*Address correspondence to: S. A. Ray, 48 Lysias Road, Clapham 
South, London SW12 8BP, U.K. 
Patients and Methods 
Over a 1-year period 169 percutaneous re- 
vascularisation procedures were performed for chronic 
disabling claudication or limb-threatening ischaemia. 
Suitable lesions included stenoses or occlusions up to 
20 cm long and above the knee. In patients with limb- 
threatening ischaemia longer lesions were considered, 
as well as infrapopliteal disease up to 2 cm in length. 
Eighty-six of the procedures were performed in 70 
patients between 0900 and 1400 hours, allowing full 
clinical and haemodynamic assessment 6 h later. The 
day before PTA each patient underwent a clinical 
assessment, which included measurements of the max- 
imum distance walked over 2 min on a treadmill 
(Powerjog, Sport Engineering Limited, Birmingham, 
U.K.) at a gradient of 10 ° at normal ambulant speed 
by the claudicants, and maximum diameters of any 
ischaemic ulcers present. Following a period of 15 rain 
rest, toe and ankle systolic arterial pressures were 
measured using appropriately-sized cuffs (Hokanson, 
Perimed, U.K.) connected to an aneroid sphygmo- 
manometer (Accoson, Abbey Surgical Ltd, Mitcham, 
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U.K.). Pulsatile flow in the foot was detected using 
a photoplethysmograph (PPG-Vasculab, Medasonics, 
Mountain View, CA, U.S.A.) sensor attached to the toe 
pulp. Pressures were expressed as toe- and ankle- 
brachial indices after measuring brachial systolic ar- 
terial pressure with an arm cuff and Doppler ultra- 
sound flowmeter (Mini Dopplex D500, Huntleigh 
Technology, Cardiff, U.K.). In our laboratory the re- 
peatability of toe- and ankle-brachial indices by this 
method is 0.16 and 0.17, respectively. 
To investigate the effect of vasodilators given after 
balloon dilatation, patients were randomised in 
double-blind fashion to receive an intra-arterial bolus 
of either 5 ml normal saline (saline group), 150 gg 
glyceryl trinitrate (GTN, Tridil, Du Pont Phar- 
maceuticals Ltd, Letchworth Garden City, Herts, U.K.) 
(GTN group) or 150 ~tg glyceryl trinitrate followed by 
a 10 mg GTN dermal patch for 24 h (Transiderm Nitro, 
Ciba Geigy, CIBA Laboratories, Horsham, West Sussex, 
U.K.) (GTN + patch group). The dosage of intra-arterial 
GTN was chosen to produce a fall in mean systemic 
arterial pressure of around 10%, a fall associated with 
beneficial haemodynamic effects. 1 The GTN patch was 
placed over the popliteal fossa of the treated leg and 
covered with a large plaster (Bandaid, Smith and 
Nephew). Similar plasters were used in all patient 
groups to blind the investigator and patients. Patients 
undergoing bilateral PTA were given the same regime 
in each leg, whilst those undergoing further PTA more 
than 6 months later were randomised again and ana- 
lysed separately. 
The toe-brachial pressure index (TBPI) and ankle- 
brachial pressure index (ABPI) was measured at the 
beginning of the procedure, immediately following 
the final balloon dilatation, and 5min after ad- 
ministration of the test bolus. On the recovery ward, 
resting pressures were repeated 1, 2, 4, 6 and 24 h 
following PTA. Patients returned after 1 week and 
after 1 and 6 months for further clinical assessment, 
including pressure measurements. At the final visit 
diagnostic 3 French arteriography of the PTA site was 
performed as a day case, obtaining antero-posterior 
and oblique digitally subtracted images. The site of 
previous balloon dilatation was assessed by su- 
perimposing the images of the artery with those taken 
immediately following PTA, and significant restenosis 
defined as luminal narrowing of 30% or more. 
Statistics 
Basic statisticai analyses were performed on a com- 
puter software package (Clinstat, Prof. JM Bland, St 
George's Hospital Medical School, London, U.K.). 
Non-paired comparisons between normally dis- 
tributed ata were performed using the Student's two- 
tailed t-test, whilst non-parametric data was analysed 
using the Mann-Whitney U test. Paired comparisons 
were analysed by either the paired t-test or Wilcoxon 
• matched pairs test. The Chi-squared test, with Yates 
correction where appropriate, was used to compare 
the incidence of events. To compare series of TBPI 
measurements, one-way analyses of variance were 
performed with Gabriel's test. Multiple regression ana- 
lysis was performed on the SAS package (SAS Institute 
Incorporated, U.S.A.). 
Results 
Patient characteristics 
Three procedures were abandoned ue to failure in 
recanalising a long occlusion, and these were not 
studied further. The remaining 83 procedures in 67 
patients underwent technically successful procedures 
(less than 30% residual stenosis). These formed the 
study group. Eleven of the 67 patients underwent 
bilateral procedures (nine simultaneous, two staged), 
and five underwent further PTA on the same leg more 
than 6 months following the first procedure. Thirty- 
three of the procedures were performed on patients 
in the saline group, 24 on patients in the GTN group 
and 26 on patients in the GTN + patch group. Table 1 
shows that the patient characteristics and indications 
for intervention of the three study groups were similar. 
Approximately two-thirds of the procedures were per- 
formed for disabling claudication, with mean resting 
ABPI measurements before intervention of 0.64 (range 
0.38-1). Fourteen procedures were performed for isch- 
aemic rest pain which regularly woke the patient at 
night and required over 2 weeks' regular analgesia. 
The mean ABPI in this group was 0.50 (range 0.18- 
0.75). Percutaneous transluminal angioplasty was per- 
formed to aid ulcer healing in 13 patients, 11 of whom 
were diabetic. Median ulcer size (maximum diameter) 
was 1.5 cm (range 2-3 cm), and none had responded to 
conservative treatment of at least 1 month's duration. 
Mean ABPI in these patients was 0.41 (range 0-0.72). 
Table 2 shows that the nature of the arterial disease 
in the three study groups was also similar. Overall, 
55% had infrainguinal PTA and 59% of the procedures 
achieved a continuously patient vessel from aorta to 
foot. 
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Table 1. Characteristics of 67 patients undergoing 83 PTA procedures for leg ischaemia. 
Saline GTN GTN + Patch Total* 
No. of patients 30 20 23 67 
Procedures 33 24 26 83 
Age (years) 68.8 65.8 68.7 67.9 
Sex (M:F) 20:10 15:5 16:7 46:21 
Diabetics 11 (37%) 7 (35%) 8 (35%) 24 (37%) 
Current smokers 9 (30%) 7 (35%) 11 (48%) 26 (39%) 
Previous mokers 18 (60%) 11 (55%) 10 (43%) 33 (50%) 
Angina/previous MI 7 (23%) 7 (35%) 8 (35%) 19 (29%) 
Previous TIA/CVA 6 (20%) 1 (5%) 3 (13%) 10 (15%) 
Claudication 22 (66%) 15 (63%) 19 (73%) 56 (67%) 
Rest pain 6 (18%) 7 (29%) 1 (4%) 14 (17%) 
Ulceration/gangrene 5 (15%) 2 (8%) 6 (23%) 13 (16%) 
*Total not always equal to the sum of three study groups, due to six patients belonging to more than one group. 
MI, myocardial infarction; TIA, transient ischaemic attack; CVA, cerebrovascular accident. 
Table 2. Naure of 83 arterial lesions prior to balloon dilatation. 
Saline GTN GTN + Patch Total 
No. of lesions 33 24 26 83 
Suprainguinal 16 (49%) 10 (42%) 11 (42%) 37 (45%) 
InfrainguinaI 17 (51%) 14 (58%) 15 (58%) 46 (55%) 
Stenosis 21 (64%) 16 (67%) 17 (65%) 54 (65%) 
Occlusion 12 (36%) 8 (33%) 9 (35%) 29 (35%) 
Median (range) length of stenosis (cm) 2 (1-16) 2 (1-16) 2 (1-16) 2 (1-16) 
Median (range) severity of stenosis (%) 85 (50-95) 90 (70-90) 90 (50-90) 90 (50-95) 
Median (range) length of occlusion (cm) 5 (2-30) 6 (2-10) 10 (4-15) 6 (2-30) 
Aortic/iliac stenosis 14 (43%) 9 (38%) 10 (38%) 33 (40%) 
Iliac occlusion 2 (6%) 1 (4%) 1 (4%) 4 (5%) 
SFA stenosis 5 (15%) 4 (17%) 5 (19%) 14 (17%) 
SFA occlusion 6 (18%) 6 (25%) 5 (19%) 17 (21%) 
Popliteal stenosis 2 (6%) 3 (12%) 2 (8%) 7 (8%) 
Popliteal occlusion 4 (12%) 0 3 (12%) 7 (8%) 
Tibial stenosis 1 (4%) 1 (1%) 
Continuous vessel to ankle 18 (55%) 13 (54%) 17 (65%) 49 (59%) 
Clinical response following PTA 
During the 6 months following PTA one claudicant 
died of myocardial  infarction. Increased treadmill dis- 
tance was recorded in 50 (91%) of the remaining 55 
claudicants (median distance walked 30 m in 2 min 
pre-PTA, 62 m 1 month post-PTA; p<0.05). Nine (64%) 
of the 14 patients with ischaemic rest pain were symp- 
tomatically improved. Complete ulcer healing was 
achieved in 10 patients (initial median max imum dia- 
meter 1.0 cm), with partial ulcer healing in the re- 
maining three (decrease in median max imum diameter 
from 1.5 cm to 0.5 m). Six months after PTA, continuing 
benefit f rom the initial procedure alone was present 
in 43 (78%) of the claudicants, six (43%) of the patients 
with rest pain, and 11 (84%) of those treated for 
ulceration. Secondary revascularisation, either per- 
cutaneous or surgical, had improved a further seven 
patients. Only one patient underwent  major limb am- 
putation, due to recurrent severe leg ulceration. Over- 
all, 82% of non-diabetics were symptomatical ly 
improved at 6 months, compared to  61% of diabetics 
(9~2=4.11,  d.f., p=0.04). There was no difference in 
the symptomatic responses to PTA of the saline, GTN, 
or GTN + patch groups. 
Haemodynamic changes following PTA 
Figures I and 2 compare the TBPI and ABPI before 
and for 6 months after successful PTA in the saline, 
GTN, and GTN +patch  groups. In the saline group 
there was a decrease in TBPI over the first 6 h following 
PTA, and significant improvement  in TBPI was delayed 
for 1 month. By contrast, in those patients given a 
bolus of GTN following balloon dilatation, TBPI was 
significantly improved within 1 week, at which time 
the measurement was similar to that observed im- 
mediately following GTN administration. 
Figure 3 shows that, on an individual basis, the toe 
systolic pressure measured immediately after GTN 
administration corresponded with the maximal toe 
pressure attained during subsequent follow-up. De- 
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Fig. 1. Changes in toe-brachial pressure index (TBPI) following PTA. 
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Fig. 2. Changes in ankle-brachiaI pressure index (ABPI) following PTA. 
layed  haemodynamic  improvement  was  noted  in a l l  
groups  and,  wh i l s t  28 (32%) of  the  83 procedures  were  
assoc ia ted  w i th  TBPI  improvement  of  0.15 or more  
24 h fo l low ing  PTA, s imi lar  TBPI  increases  were  noted  
at 1 month  after  42 (50%) of the procedures .  
To ana lyse  the  changes  wh ich  normal ly  occur  fol- 
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following PTA with maximal toe pressure during follow-up. 
lowing PTA further without adjuvant pharmaco- 
therapy, the TBPI data of the saline group were also 
analysed according to severity of symptoms, site of 
lesion, nature of the treated segment, state of the distal 
vasculature, and diabetic status. Before PTA, resting 
TBPI were higher in claudicants (p<0.01) and patients 
with stenotic or suprainguinal lesions. The delayed 
pattern of TBPI improvement following PTA was ob- 
served regardless of the severity of symptoms, diabetic 
status or the presence of a continuous distal run-off 
vessel from the site of dilatation to the ankle. However, 
there was little or no reduction in TBPI either im- 
mediately following balloon dilatation or during the 
following 6 h in patients undergoing reopening of 
occlusive lesions, and maximal TBPI improvement was 
achieved by 1 week. 
Arteriographic patency following PTA 
Four patients did not have arteriographic follow-up 
due to death (one patient) of disabling stroke (three 
patients). Recurrent disease was detected following 27 
(33%) of the 79 reimaged cases, with no significant 
difference in the restenosis rates of the saline (29%), 
GTN (36%), or GTN+patch (39%) groups. Overall, 
restenosis was significantly more frequent following 
PTA below the inguinal igament (44% vs. 21%, Z2= 
4.23.1 d.f., p = 0.04) or following PTA for rest pain or 
ulceration rather than claudication (58% vs. 24%, Z2= 
8.94, 1 d.f., p<0.01). Occlusive lesions (47% vs. 27%, 
9~2 =3.35, 1 d.f., p = 0.07) and PTA in diabetics (44% vs. 
29%, ~2= 1.92, 1 d.f., p=0.17) were also more likely to 
undergo restenosis, but this was not significant. Nei- 
ther the patency of the run-off vessels from the PTA 
site to the ankle, nor continued smoking influenced 
recurrent disease at 6 months. 
Whilst recurrent symptoms were noted in only five 
of the 12 claudicants suffering restenosis, ix of the 
eight patients treated for ischaemic rest pain and de- 
veloping recurrent disease became symptomatic. Re- 
stenosis occurred in seven (54%) of the 13 patients 
treated for ulceration and was associated with a return 
of claudication i two, but never renewed tissue nec- 
rosis. 
Relationship between haemodynamic changes and 
arteriographic patency following PTA 
Figure 4 compares the changes in TBPI in those patients 
whose dilatation sites remained free of significant 
disease 6 months following PTA (patent group) and 
those who suffered significant (>30% restenosis) re- 
current disease at the PTA site (restenosis group). 
Before PTA, TBPI were significantly higher in the 
patent group and improved gradually over the first 
month following balloon dilatation. In the restenosis 
group TBPI increased rapidly to peak 1 week after 
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Fig. 4. Changes in toe-brachial pressure index (TBPI) following PTA in patients with patent or restenosed PTA site after 6 months. 
PTA, before returning to pre-dilatation levels within 
6 months. 
Haemodynamic  parameters recorded during the 
first 24 h following PTA were not useful in identifying 
those procedures at higher risk of restenosis within 
the subsequent 6 months. However,  a TBPI increase 
of more than 0.15 1 week following PTA carried a 
positive predictive value for restenosis within 6 
months of 62%. This was significantly more frequent 
than the restenosis rate, 22%, observed when the TBPI 
improvement  at i week was 0.15 or less. This was not 
s imply due to the lower TBPI before PTA in the 
restenosis group, as there was no significant correlation 
between TBPI pre-PTA and the TBPI increase after 
1 week ( r=-0 .23 ,  p=0.10). The regression analysis 
shown in Table 3 also confirms this relationship to be 
independent of other variables thought o be associated 
with restenosis, and demonstrates that rest pain or 
ulceration was the only other characteristic associated 
with recurrent disease. 
Most authors use a sustained improvement  in ABPI 
or TBPI of 0.15 or greater following PTA as the only 
objective evidence of continuing patency. Applying 
these criteria to the patients in this study, 6-month 
patency would have been reported as 44% using TBPI, 
or 49% using ABPI, when in fact patency determined 
angiographically was approximately 20% higher. 
Table 3. Predictive va lue of pre-PTA characteristics and post-PTA 
haemodynamic  changes for restenosis at 6 months.  
Odds 95% confidence 
Risk factor ratio limits p 
Limb-threatening ischaemia 5.9 1.1-33 0.04 
Diabetes 1.3 0.3-5.3 0.73 
Occlusive disease 1.9 0.1-2.2 0.38 
Discontinuous run-off 1.5 0.3-8.4 0.63 
One week TBPI increase 
>0.15 4.9 1.1-22 0.03 
Discussion 
Haemodynamic changes following PTA 
Over the study period nearly 60% of lower limb re- 
vascularisation procedures in our department were 
performed by percutaneous methods. This is in keep- 
ing with recent reports highlighting the trend towards 
less invasive methods of treating peripheral isch- 
aemia. 2Surprisingly, there has not been a similar in- 
crease in information concerning haemod3~namic 
changes following PTA. The small amount of data that 
is available has highlighted delayed improvement  in 
ABPI, in contrast o the almost immediate return to 
normal ABPI after surgical bypass. 3~ In this study we 
measured systolic pressure at the toe in order to 
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eliminate falsely elevated ankle pressure meas- 
urements due to calcified, incompressible tibial ar- 
teries. 7'8 We were able to confirm a delay of up to 1 
month in maximal TBPI increase, the actual period 
of improvement depending on the nature of arterial 
disease treated. This observation is important when 
using pressure measurements to determine the success 
of percutaneous procedures. . For example, when as- 
sessing the full haemodynamic effect of PTA, pressure 
measurements should be delayed for at least 1 week 
following dilatation of stenotic or infrainguinal dis- 
ease, and for 1 month following PTA of occlusive 
or aortoiliac disease. By doing so, the proportion of 
'haemodynamic' successes (TBPI increase of 0.15 or 
more) in this study increased from 32% of the pro- 
cedures 24 h following PTA to 50% 1 month later. 
Hypotheses for the delayed haemodynamic im- 
provement following PTA include relief of post-trau- 
matic vasospasm, remodelling or lysis of thrombus at 
the site of PTA, clearance of distal emboli, delayed 
improvement in collateral circulation, and post-re- 
vascularisation oedema. 3'4'9-~3 Reflex vasoconstriction 
is a well recognised consequence of arterial trauma, 
of which PTA is a severe example, and a degree of 
vasospasm following these procedures i  likely. This 
reflects a decrease in local vasodilators uch as the 
prostaglandins PGI1, PGE2 and endothelial-derived re-
laxing factor (EDRF)J 4'15 as well as an increase in 
vasoconstrictors such as thromboxane A 2 and hydroxy- 
peroxy acids. 16 This imbalance is also likely to favour 
platelet aggregation at the PTA site and further elease 
of vasoconstrictors. Empirical administration of 
spasmolytics is a common method of treating the 
vasospasm arteriographically observed during per- 
cutaneous revascularisation proceduresJ 7 Nitro- 
glycerin (GTN) has been shown to prevent coronary 
vasoconstriction following PTA9 probably by relaxing 
vascular smooth muscle. This involves an endo- 
thelium-independent mechanism 19'2° and is therefore 
remarkably efficacious in relieving arterial spasm in 
areas of endothelial injury. 21 Whether the ad- 
ministration of a single GTN bolus is of any benefit 
in terms of subsequent haemodynamic changes or 
patency has not been investigated. Nor has the use of 
an additional GTN patch, which produces plasma 
levels i h after application similar to that observed 
with an intravenous infusion. = The drug is detected 
in plasma 30-60 rain after application, with steady- 
state plasma concentrations related to the dose 
administered and persisting for up to 24 h. No drug 
is measurable within i h of patch" removal. 
The administration of an intra-arterial GTN bolus 
immediately following technically successful PTA was 
associated with reversal of the initial fall in TBPI 
observed following administration of saline placebo. 
Subsequent improvement of TBPI was also quicker 
and greater, though still delayed. That administration 
of a single bolus of GTN following PTA can produce 
sustained haemodynamic benefit suggests that the 
mechanism isnot entirely one of vasodilatation, which 
would tend to be transient. Experimental evidence 
also supports a non-vasodilator effect of GTN. Werns 
eta[ .  23 noted that infusion of GTN into dog carotid 
arteries had antithrombotic effects which were not 
matched by infusion of non-nitrates producing equi- 
valent vasodilatation. Lam et a[. 24 have also shown 
that administration of an intravenous nitroglycerin 
infusion during deep arterial wall injury in pigs re- 
duces not only arterial spasm in adjacent segments, 
but also immediate platelet deposition at the site of 
trauma by nearly 75%. By contrast, other non-nitrate 
spasmolytics uch as verapamil, nifedipine, prosta- 
cyclin and serotonin had no effect on platelet de- 
position. 25-28 Despite the immediate haemodynamic 
benefits of administering GTN immediately following 
PTA, there was no evidence in this study of improved 
long-term haemodynamics or patency rates with its 
use. 
The observation that TBPI improvement is quicker 
following reopening of occluded segments in com- 
parison to dilatation of stenotic disease is unexpected, 
given that the former procedure is likely to cause 
greater local trauma and resulting vasospasm and 
embolisation. It is possible that delayed haemo- 
dynamic improvement is related to dissolution of oc- 
cluding thrombus at the site of PTA. This is supported 
by Henderson et al. 's report of serial colour-flow Du- 
plex following PTA of 49 lesions in 37 patientsJ 3A 
significant increase in lumen diameter was observed 
immediately following dilatation of 48 lesions, and 
further luminal dilatation was observed in 23 during 
the next 4 weeks. If this is due to lysing of thrombus 
deposits at the site of PTA, an increase in distal per- 
fusion pressure following reopening of an occlusion 
will be observed as soon as such thrombus is non- 
occlusive. By contrast, haemodynamic mprovement 
following dilatation of stenotic disease will only be 
noted once the platelet hrombus occupies less of the 
luminal cross-section than the original lesion. 
Because GTN has antiplatelet actions, it is con- 
ceivable that its sustained haemodynamic effects are 
mediated by inhibition of immediate platelet and 
thrombus accumulation at the site of PTA, rather than 
simple spasmolysis. This would also explain the cor- 
relation between TBPI measurements aken at this 
time and maximum values during subsequent follow- 
up because the PTA site, as well as distal vessel tone, 
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immediately following GTN administration would 
closely resemble that observed following the eventual 
resolution of platelet thrombus and vasospasm. Use 
of a 10 mg GTN slow release patch in addition to 
the bolus may further delay platelet accumulation, 
although the pressure changes at 6 months in patients 
given GTN are similar whether a patch is applied or 
not. 
Restenosis fol lowing PTA 
The patency of lower limb revascularisation pro- 
cedures is usually inferred if, in addition to clinical 
improvement,  he ABPI or TBPI remain improved by 
0.10-0.15 or more. 29'B° However,  residual disease in 
arterial segments distal to the PTA site compromises 
the increase in perfusion pressure, Bl'B2 and imaging of 
the PTA site is therefore necessary to determine pat- 
ency. Although Duplex scanning is often used to deter- 
mine residual stenosis following PTA, results appear 
to be operator-dependent. 3B'B4Arteriography is invasive 
and t ime-consuming and, where routine arteriographic 
surveillance following PTA has been offered, over 30% 
of patients have refused, ss The use of 3 French catheters 
for arteriography allows outpatient investigation with 
adequate imaging, and fewer complications related to 
arterial puncture. B6 None of the 63 available patients 
in our series refused such imaging, and there was only 
one complication, subintimal passage of the catheter, 
which did not require intervention. The incidence of 
restenosis at 6 months, 33% using arteriography, would 
have been reported as 56% had a TBPI increase of 0.15 
or more been required to infer patency. Procedures 
for occlusive disease in diabetics or smokers, and in 
those without continuous run-off vessels, were not 
independently associated with restenosis at 6 months. 
This contradicts ome reports where such risk factors 
have been associated with recurrent symptoms. B7~4° 
However,  it is likely that a significant proport ion of 
reported 'failures' following PTA are due to pro- 
gression of distal disease rather than true restenosis. 
Table 3 shows that an increase of TBPI of 0.15 or 
more 1 week after PTA was independently associated 
with restenosis within the next 6 months. This was a 
most surprising finding, and counter to expectations. 
As the pre-PTA TBPI was also significantly lower in 
those who developed restenosis, this may simply be 
an indirect reflection of the relationship between the 
severity of ischaemia nd recurrent disease. However,  
it is also likely that a large TBPI increase following 
PTA is related to the degree of radial expansion and, 
therefore, the trauma of the dilatation. It has already 
been demonstrated that platelet accumulation at the 
site of experimental PTA is proportional to histological 
damage, 15'41 and that radiolabelled platelet uptake at 
the site of PTA is related to subsequent symptomatic 
failure. 42 It would appear that the greater the im- 
provement in pressure-indices following PTA, the less 
durable the procedure. Whilst restenosis tended to be 
symptomatic in patients treated for ischaemic rest 
pain, recurrent disease in those patients treated for 
ulceration was seldom associated with renewed tissue 
necrosis. The symptomatic relief afforded by tem- 
porari ly increased peripheral perfusion appears to be 
clinically more important than the subsequent re- 
currence of disease. 
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